ArticleCancer biomarkers : section A of Disease markers2025

Evaluating the efficacy of PARP inhibitor in ARID1A-deficient colorectal cancer: A

Rui Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.